Urgent.News

What's breaking now, across thousands of outlets.

Science

Targeting AURKA by CRISPR/SaCas9 Alters Cell Cycle Progression and Enhances Lenvatinib-Associated Reduction in Cell Viability in Hepatocellular Carcinoma: An Integrated In Silico and HepG2 in Vitro Study

Hepatocellular carcinoma (HCC) presents substantial clinical concerns as a result of its high treatment resistance, frequent recurrence, and strong correlation with chronic liver diseases. Aurora kinase A (AURKA) is overexpressed in HCC correlating with poor prognosis and treatment resistance. Our bioinformatics analyses revealed that AURKA overexpression in HCC is associated with mitotic…

We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.

Read the original at biorxiv.org →

More in Science

More from Wednesday 18 November →